Application Notes

Cellastim S – Reconstitution Application Note

Optiferrin – Using rTransferrin in the Expansion of Hematopoietic Stem Cells Application Note

rHSA Reconstitution Video Protocol

Cell Culture Media & The Emergence of Blood-Free Components

Exbumin – Stabilizing Virus with Albumin to Improve Yield Application Note

ITSE+A – Reducing Serum-Associated Contaminants from Growth Media in Primary Cell Culture Application Note

Blog

Emergence of a Blood-Free rHSA

Journal Articles (DOI Links)

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

Accurate nanoelectrode recording of human pluripotent cell-derived cardiomyocytes for assaying drugs and modeling disease

Posters

Adherent HEK293t Cells Cultured in Pall’s iCELLis® Bioreactor with OptiPEAK HEK293t Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times

Product Brochures

2021 Product Catalog

ITSE AF – Brochure

Optiferrin – Product Brochure

Product Specifications

ITS – Specifications

ITSE+A – Specifications

SDS

Exbumin – Safety Data Sheet

ITSE AF – Safety Data Sheet

Optibumin – Safety Data Sheet

Use Guidelines

Cellastim S – Guidelines for Use

Exbumin – Guidelines for Use

ITS – Guidelines for Use

ITSE AF – Guidelines for Use

ITSE+A – Guidelines for Use

Optiferrin – Guidelines for Use

Webinar

Accelerating Vaccine Development Through Use of Blood-Free Components

White Papers

Enhancement of Transient Transfection with Serum-Free and Blood-Free Transferrin